A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - Dec 5, 2023 - P2 | N=24 | Recruiting | Sponsor: Kezar Life Sciences, Inc. | Phase classification: P2a ➔ P2
Phase classification • Autoimmune Hepatitis • Hepatology • Immunology • Inflammation
|